Generic Lanoxicaps
Common uses: Lanoxicaps (Digoxin) is a cardiac glycoside used to treat heart failure and some irregular heart rhythms. Your pharmacist may know of alternate uses for Lanoxicaps (Digoxin). Click for more Lanoxicaps details.
What is Generic Lanoxicaps?
Generic Lanoxicaps, like all generics, is the name given to the
prescription Digoxin medication manufactured by any company other than the
original inventor of Lanoxicaps. The only true difference between brand name Lanoxicaps
and generic Lanoxicaps is that generic Lanoxicaps is always less expensive.
Also known as: Digoxina, Lanoxin, Novo-Digoxin, Digoxin (generic name).
Generic Lanoxicaps and Lanoxin are at Freedom Pharmacy | *** SAVE 5% MORE WITH DISCOUNT CODE: MYN-05 *** | | Medication | Strength | Quantity | Price | Freedom Pharmacy | | Digoxin | 0,25 mg | 50 tablets | $57.42 | Order | | Lanoxin | 62.5 mg pg | 250 tablets | $44.32 | Order | | Lanoxin | 250 mcg | 100 tablets | $49.87 | Order | | Lanoxin | 250 mcg | 250 tablets | $81.48 | Order |
Generic Lanoxicaps manufactured by Mibe, Digoxina made by Kern Pharma, Lanacordin Pediatrico manufactured by Kern Pharma, and Lenoxin by Aspen Pharma Ireland Limited are at Goldpharma | Medication | Strength | Quantity | Price | Goldpharma | | Digacin | 0.25 mg | 84 tablets | $28.64 | Order | | Digoxina | 0.25 mg | 50 tablets | $9.23 | Order | | Digoxina | 0.5 mg | 5x2ml injection iv | $9.11 | Order | | Digoxina Teofarma | 0.25 mg | 5x1ml injection iv | $6.31 | Order | | Lanacordin Pediatrico | 0.25 mg | 60ml solution | $10.00 | Order | | Lenoxin | 0.05 mg | 60ml solution | $28.32 | Order | | Lenoxin | 0.25 mg | 100 tablets | $30.13 | Order | | Lenoxin Mite | 0.125 mg | 100 tablets | $27.61 | Order |
Buy Generic Lanoxicaps - No Prior Prescription Needed*
How To Buy Generic Lanoxicaps Online
Buy discount generic Lanoxicaps (Digoxin) online by clicking on one of the low
prices shown. You'll be sent to our secure shopping cart where you can safely
complete your transaction.
Lanoxicaps - Health Bulletin
Cinqair Approved for Severe AsthmaWEDNESDAY, March 23, 2016 (HealthDay News) -- Cinqair (reslizumab) has been approved by the U.S. Food and Drug Administration to treat severe asthma among adults 18 and older. The drug is to be used in combination with other medications, the agency noted. Read entire article...
Please verify your local import regulations; the ability for a pharmacy to
offer a medication without a prescription does not negate any local requirement
you may have.
NOTICE: By using this site, you agree to verify and comply with your
country's rules and regulations should you undertake to purchase from any of
the listed pharmacies.
|
